Enhancements    

DEVELOPMENT OF IMAGING NANOPROBE FOR REAL-TIME NONINVASIVE DIAGNOSIS OF CARDIOTOXICITY INDUCED BY CANCER CHEMOTHERAPEUTIC AGENTS

DEVELOPMENT OF IMAGING NANOPROBE FOR REAL-TIME NONINVASIVE DIAGNOSIS OF CARDIOTOXICITY INDUCED BY CANCER CHEMOTHERAPEUTIC AGENTS
PI: Md Nurunnabi
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
Pharmaceutical Sciences
Amount awarded: $100,000

This project develops an injectable imaging nanoprobe that can be monitored externally, in real-time, to quantify toxicity in cardiac muscle cells (cardiomyocytes) in order for patients receiving cancer chemotherapy to avoid chronic cardiac dysfunction.

Posting date: Wed, 05/06/2020

Award start date: Wed, 04/01/2020
Award end date: Thu, 12/31/2020